Avantor, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Avantor, Inc. (AVTR) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $60.20 million as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-11
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $60.20M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $63.10M.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $19.50M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $13.90M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $60.20M 10-K · filed 2026-02-11 |
| 2024-12-31 | $63.10M 10-K · filed 2025-02-07 |
| 2023-12-31 | $19.50M 10-K · filed 2024-02-14 |
| 2022-12-31 | $13.90M 10-K · filed 2023-02-14 |
| 2021-12-31 | $20.80M 10-K · filed 2022-02-11 |
| 2020-12-31 | $20.20M 10-K · filed 2021-02-16 |
| 2019-12-31 | $20.30M 10-K · filed 2020-02-14 |
| 2019-09-30 | $26.00M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $25.00M 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |